Andrew Fairbairn

8.1k total citations
74 papers, 6.1k citations indexed

About

Andrew Fairbairn is a scholar working on Psychiatry and Mental health, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Andrew Fairbairn has authored 74 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Psychiatry and Mental health, 15 papers in Pharmacology and 15 papers in Cellular and Molecular Neuroscience. Recurrent topics in Andrew Fairbairn's work include Cholinesterase and Neurodegenerative Diseases (13 papers), Alzheimer's disease research and treatments (12 papers) and Dementia and Cognitive Impairment Research (12 papers). Andrew Fairbairn is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (13 papers), Alzheimer's disease research and treatments (12 papers) and Dementia and Cognitive Impairment Research (12 papers). Andrew Fairbairn collaborates with scholars based in United Kingdom, United States and Tanzania. Andrew Fairbairn's co-authors include Robert H. Perry, Elaine K. Perry, Ian G. McKeith, J. Candy, Paul M. Thompson, G. Blessed, Garry Blessed, Dorothy Irving, R. H. Perry and B.E. Tomlinson and has published in prestigious journals such as The Lancet, Neurology and Biological Psychiatry.

In The Last Decade

Andrew Fairbairn

71 papers receiving 5.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Fairbairn United Kingdom 36 1.9k 1.8k 1.6k 1.5k 1.3k 74 6.1k
Roger Lane United States 42 2.2k 1.2× 1.3k 0.7× 1.5k 0.9× 649 0.4× 2.4k 1.8× 111 6.4k
Zaven S. Khachaturian United States 25 1.5k 0.8× 3.2k 1.8× 499 0.3× 1.4k 0.9× 1.3k 1.0× 81 6.2k
Donald J. Connor United States 36 1.3k 0.7× 2.0k 1.1× 1.9k 1.2× 995 0.7× 369 0.3× 67 5.4k
G. Blessed United Kingdom 27 3.7k 2.0× 4.0k 2.2× 1.4k 0.9× 2.4k 1.6× 2.6k 1.9× 42 10.9k
B. E. Tomlinson United Kingdom 26 3.4k 1.8× 3.6k 2.0× 1.2k 0.7× 1.9k 1.3× 2.0k 1.5× 48 9.9k
C.Q. Mountjoy United Kingdom 31 1.8k 1.0× 1.8k 1.0× 603 0.4× 1.8k 1.2× 957 0.7× 50 5.5k
Jan Marcusson Sweden 45 1.2k 0.6× 1.7k 0.9× 943 0.6× 2.4k 1.6× 921 0.7× 157 6.6k
Dushyant P. Purohit United States 37 1.3k 0.7× 2.2k 1.2× 717 0.4× 1.0k 0.7× 745 0.6× 66 4.9k
John P. Blass United States 59 1.1k 0.6× 4.7k 2.6× 2.2k 1.3× 2.3k 1.5× 1.0k 0.8× 256 11.7k
Hans Basun Sweden 50 2.1k 1.1× 4.2k 2.3× 736 0.4× 694 0.5× 869 0.7× 133 7.4k

Countries citing papers authored by Andrew Fairbairn

Since Specialization
Citations

This map shows the geographic impact of Andrew Fairbairn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Fairbairn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Fairbairn more than expected).

Fields of papers citing papers by Andrew Fairbairn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Fairbairn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Fairbairn. The network helps show where Andrew Fairbairn may publish in the future.

Co-authorship network of co-authors of Andrew Fairbairn

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Fairbairn. A scholar is included among the top collaborators of Andrew Fairbairn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Fairbairn. Andrew Fairbairn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Paxton, Roger, et al.. (2006). Research, audit and quality improvement. International Journal of Health Care Quality Assurance. 19(1). 105–111. 5 indexed citations
2.
O’Brien, John T., Louise Robinson, & Andrew Fairbairn. (2001). Proposed shared care protocol between primary and secondary care for the ongoing management of those on anti-dementia medication. 7(3). 111–113. 2 indexed citations
3.
Ballard, Clive, Jane Fossey, Robert Howard, et al.. (2001). Quality of care in private sector and NHS facilities for people with dementia: cross sectional survey: Table 1.. BMJ. 323(7310). 426–427. 77 indexed citations
4.
McKeith, Ian G., Clive Ballard, Robert H. Perry, et al.. (2000). Prospective validation of Consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology. 54(5). 1050–1058. 335 indexed citations
5.
Fairbairn, Andrew. (2000). An old age psychiatrist at the Department of Health. International Journal of Geriatric Psychiatry. 15(8). 762–765.
6.
Kay, D. W. K., Michael Dewey, Ian G. McKeith, et al.. (1998). Do experienced diagnosticians agree about the diagnosis of dementia from survey data? The effects of informants' reports and interviewers' vignettes. International Journal of Geriatric Psychiatry. 13(12). 852–862. 14 indexed citations
7.
Piggott, Margaret A., Elaine K. Perry, Elizabeth F. Marshall, et al.. (1998). Nigrostriatal dopaminergic activities in dementia with lewy bodies in relation to neuroleptic sensitivity: comparisons with parkinson’s disease. Biological Psychiatry. 44(8). 765–774. 49 indexed citations
8.
Ballard, Clive, et al.. (1997). A Prospective Study of Psychotic Symptoms in Dementia Sufferers: Psychosis in Dementia. International Psychogeriatrics. 9(1). 57–64. 35 indexed citations
9.
Perry, Elaine K., Christopher M. Morris, J.A. Court, et al.. (1995). Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: Possible index of early neuropathology. Neuroscience. 64(2). 385–395. 309 indexed citations
10.
McKeith, Ian G., Andrew Fairbairn, P. Brian Moore, et al.. (1994). An evaluation of the predictive validity and inter‐rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology. 44(5). 872–872. 142 indexed citations
11.
McKeith, Ian G., Andrew Fairbairn, R.H. Perry, & Paul M. Thompson. (1994). The Clinical Diagnosis and Misdiagnosis of Senile Dementia of Lewy Body Type (SDLT). The British Journal of Psychiatry. 165(3). 324–332. 72 indexed citations
12.
Perry, Elaine K., Dorothy Irving, Janet Kerwin, et al.. (1993). Cholinergic Transmitter and Neurotrophic Activities in Lewy Body Dementia. Alzheimer Disease & Associated Disorders. 7(2). 69–79. 174 indexed citations
13.
Leake, A., Elaine K. Perry, Robert H. Perry, et al.. (1991). Neocortical concentrations of neuropeptides in senile dementia of the alzheimer and lewy body type: Comparison with parkinson's disease and severity correlations. Biological Psychiatry. 29(4). 357–364. 26 indexed citations
14.
Leake, A., Andrew Fairbairn, Ian G. McKeith, & I. Nicol Ferrier. (1991). Studies on the serotonin uptake binding site in major depressive disorder and control post-mortem brain: Neurochemical and clinical correlates. Psychiatry Research. 39(2). 155–165. 72 indexed citations
15.
Meudell, Peter R., A.R. Mayes, Christopher J. MacDonald, Alan D. Pickering, & Andrew Fairbairn. (1991). Korsakoff Amnesics are Poor at Judging the Sequence of two Tones. Cortex. 27(3). 431–439. 4 indexed citations
16.
Leake, A., Elaine K. Perry, Robert H. Perry, Andrew Fairbairn, & I. Nicol Ferrier. (1990). Cortical concentrations of corticotropin-releasing hormone and its receptor in Alzheimer type dementia and major depression. Biological Psychiatry. 28(7). 603–608. 39 indexed citations
17.
Ferrier, I. Nicol, A. Leake, Geoffrey A. Taylor, et al.. (1990). Reduced Gastrointestinal Absorption of Calcium in Dementia. Age and Ageing. 19(6). 368–375. 33 indexed citations
18.
Fairbairn, Andrew, et al.. (1989). Lofepramine versus dothiepin in the treatment of depression in elderly patients. International Journal of Clinical Practice. 43(2). 55–60. 6 indexed citations
19.
Perry, Elaine K., R. H. Perry, D J Dick, et al.. (1987). Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases.. Journal of Neurology Neurosurgery & Psychiatry. 50(6). 806–809. 139 indexed citations
20.
Mayes, Andrew R., Alan D. Pickering, & Andrew Fairbairn. (1987). Amnesic sensitivity to proactive interference: Its relationship to priming and the causes of amnesia. Neuropsychologia. 25(1). 211–220. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roger Lane Breakdown of academic impact, for papers by Zaven S. Khachaturian Breakdown of academic impact, for papers by Donald J. Connor Breakdown of academic impact, for papers by G. Blessed Breakdown of academic impact, for papers by B. E. Tomlinson Breakdown of academic impact, for papers by C.Q. Mountjoy Breakdown of academic impact, for papers by Jan Marcusson Breakdown of academic impact, for papers by Dushyant P. Purohit Breakdown of academic impact, for papers by John P. Blass Breakdown of academic impact, for papers by Hans Basun
Rankless by CCL
2026